Harrison.ai has announced a strategic partnership with Apollo Radiology International (ARI) teleradiology to deploy its Chest X-ray (CXR) and Brain CT (CTB) AI tools across ARI’s global reporting offerings.
CTB is trained to detect up to 130 findings on noncontrast head CT, while CXR is designed to detect up to 124 findings, according to the firm. Both feature embedded triage capability.
The company has obtained various regulatory clearances, including U.S. Food and Drug Administration 510(k)s and breakthrough device designations in the U.S. Cleared for sale in 40 countries, the software tools may be useful as second readers, for improving operational efficiency, and supporting out-of-hours care, the company added.
![A normal mammogram confirmed by three-year radiologic follow-up illustrates reader-marked regions of interest (ROIs) during (A) unaided (round 1) and (B) artificial intelligence (AI)–assisted (round 2) reading. Each colored dot represents an ROI for recall by a human reader. Readers could mark more than one ROI per case, represented by multiple dots of the same color. During AI-assisted reading, the AI system displayed three visible prompts: two with suspicion of malignancy scores of 35% (left mediolateral oblique [L MLO] and craniocaudal [L CC]) and one with a suspicion of malignancy score of 10% (right craniocaudal [R CC]), shown as polygonal overlays. Without AI, six of 10 readers (60%) marked a false-positive ROI. With AI assistance, this fell to two of 10 (20%). R MLO = right mediolateral oblique.](https://img.auntminnie.com/mindful/smg/workspaces/default/uploads/2026/07/2026-07-14-radiology-mammogram-ai-auto-bias.H0bYO8QlWs.jpg?auto=format%2Ccompress&dpr=2&fit=crop&h=167&q=70&w=250)
